97 related articles for article (PubMed ID: 17438698)
1. [Amelioration of insulin resistance after scald by c-Jun N-terminal kinase inhibitor in rat].
Chen XL; Xia ZF; Wei D; Ben DF; Tang HT; Ge SD
Zhonghua Shao Shang Za Zhi; 2006 Dec; 22(6):466-8. PubMed ID: 17438698
[TBL] [Abstract][Full Text] [Related]
2. [Role of c-Jun NH (2)-terminal kinase in insulin resistance after burn].
Chen XL; Xia ZF; Wei D; Ben DF; Tang HT; Ge SD
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):62-4. PubMed ID: 17403295
[TBL] [Abstract][Full Text] [Related]
3. mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn.
Xin-Long C; Zhao-Fan X; Dao-Feng B; Wei D
Burns; 2011 Feb; 37(1):86-93. PubMed ID: 20594757
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
[TBL] [Abstract][Full Text] [Related]
5. Myocardial protective effects of a c-Jun N-terminal kinase inhibitor in rats with brain death.
Guo W; Cao S; Yan B; Zhang G; Li J; Zhao Y; Zhang S
J Cell Mol Med; 2016 Jul; 20(7):1214-8. PubMed ID: 27072084
[TBL] [Abstract][Full Text] [Related]
6. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion.
Prada PO; Zecchin HG; Gasparetti AL; Torsoni MA; Ueno M; Hirata AE; Corezola do Amaral ME; Höer NF; Boschero AC; Saad MJ
Endocrinology; 2005 Mar; 146(3):1576-87. PubMed ID: 15591151
[TBL] [Abstract][Full Text] [Related]
7. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125.
Williams AS; Issa R; Leung SY; Nath P; Ferguson GD; Bennett BL; Adcock IM; Chung KF
J Pharmacol Exp Ther; 2007 Jul; 322(1):351-9. PubMed ID: 17460151
[TBL] [Abstract][Full Text] [Related]
9. Dimethylaminopurine inhibits metabolic effects of insulin in primary adipocytes.
Göransson O; Rydén M; Nilsson R; Arner P; Degerman E
J Nutr Biochem; 2004 May; 15(5):303-12. PubMed ID: 15135155
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation.
Zhang Q; Carter EA; Ma BY; White M; Fischman AJ; Tompkins RG
Life Sci; 2005 Oct; 77(24):3068-77. PubMed ID: 15982669
[TBL] [Abstract][Full Text] [Related]
11. Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance.
Vinayagamoorthi R; Bobby Z; Sridhar MG
J Endocrinol; 2008 May; 197(2):287-96. PubMed ID: 18434358
[TBL] [Abstract][Full Text] [Related]
12. A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells.
Masamune A; Kikuta K; Suzuki N; Satoh M; Satoh K; Shimosegawa T
J Pharmacol Exp Ther; 2004 Aug; 310(2):520-7. PubMed ID: 15056726
[TBL] [Abstract][Full Text] [Related]
13. Increased insulin receptor substrate 1 serine phosphorylation and stress-activated protein kinase/c-Jun N-terminal kinase activation associated with vascular insulin resistance in spontaneously hypertensive rats.
Sugita M; Sugita H; Kaneki M
Hypertension; 2004 Oct; 44(4):484-9. PubMed ID: 15302844
[TBL] [Abstract][Full Text] [Related]
14. The c-Jun N-terminal kinase inhibitor SP600125 is neuroprotective in amygdala kindled rats.
Chen X; Wu J; Hua D; Shu K; Wang JZ; Li L; Lei T
Brain Res; 2010 Oct; 1357():104-14. PubMed ID: 20692238
[TBL] [Abstract][Full Text] [Related]
15. Post-burn hepatic insulin resistance is associated with endoplasmic reticulum (ER) stress.
Gauglitz GG; Halder S; Boehning DF; Kulp GA; Herndon DN; Barral JM; Jeschke MG
Shock; 2010 Mar; 33(3):299-305. PubMed ID: 22011639
[TBL] [Abstract][Full Text] [Related]
16. Glucose-Induced β-Cell Dysfunction In Vivo: Evidence for a Causal Role of C-jun N-terminal Kinase Pathway.
Tang C; Yeung LSN; Koulajian K; Zhang L; Tai K; Volchuk A; Giacca A
Endocrinology; 2018 Nov; 159(11):3643-3654. PubMed ID: 30215691
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
[TBL] [Abstract][Full Text] [Related]
18. Blockade of c-Jun N-terminal kinase activation abrogates hyperglycemia-induced yolk sac vasculopathy in vitro.
Yang P; Zhao Z; Reece EA
Am J Obstet Gynecol; 2008 Mar; 198(3):321.e1-7. PubMed ID: 18177823
[TBL] [Abstract][Full Text] [Related]
19. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
Sharfi H; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
[TBL] [Abstract][Full Text] [Related]
20. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance.
Wei Y; Pagliassotti MJ
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E926-33. PubMed ID: 15198936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
